225 related articles for article (PubMed ID: 17977009)
1. Nebivolol reduces asymmetric dimethylarginine in endothelial cells by increasing dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression and activity.
Garbin U; Pasini AF; Stranieri C; Manfro S; Boccioletti V; Cominacini L
Pharmacol Res; 2007 Dec; 56(6):515-21. PubMed ID: 17977009
[TBL] [Abstract][Full Text] [Related]
2. Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients.
Pasini AF; Garbin U; Stranieri C; Boccioletti V; Mozzini C; Manfro S; Pasini A; Cominacini M; Cominacini L
Am J Hypertens; 2008 Nov; 21(11):1251-7. PubMed ID: 18772860
[TBL] [Abstract][Full Text] [Related]
3. The effect of nebivolol on asymmetric dimethylarginine system in spontaneously hypertension rats.
Wang Y; Zhang M; Liu Y; Liu Y; Chen M
Vascul Pharmacol; 2011; 54(1-2):36-43. PubMed ID: 21167314
[TBL] [Abstract][Full Text] [Related]
4. Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells.
Liu LH; Guo Z; Feng M; Wu ZZ; He ZM; Xiong Y
Cell Physiol Biochem; 2012; 30(6):1413-22. PubMed ID: 23171931
[TBL] [Abstract][Full Text] [Related]
5. Dysfunction of endothelial NO system originated from homocysteine-induced aberrant methylation pattern in promoter region of DDAH2 gene.
Zhang JG; Liu JX; Li ZH; Wang LZ; Jiang YD; Wang SR
Chin Med J (Engl); 2007 Dec; 120(23):2132-7. PubMed ID: 18167189
[TBL] [Abstract][Full Text] [Related]
6. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
Feng M; Liu L; Guo Z; Xiong Y
Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305
[TBL] [Abstract][Full Text] [Related]
7. Regulation by DDAH/ADMA pathway of lipopolysaccharide-induced tissue factor expression in endothelial cells.
Xin HY; Jiang DJ; Jia SJ; Song K; Wang GP; Li YJ; Chen FP
Thromb Haemost; 2007 May; 97(5):830-8. PubMed ID: 17479195
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo gene transferring of human dimethylarginine dimethylaminohydrolase-2 improved endothelial dysfunction in diabetic rat aortas and high glucose-treated endothelial cells.
Lu CW; Guo Z; Feng M; Wu ZZ; He ZM; Xiong Y
Atherosclerosis; 2010 Mar; 209(1):66-73. PubMed ID: 19775692
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of resveratrol derivative BTM-0512 on high glucose-induced cell senescence involves dimethylaminohydrolase/asymmetric dimethylarginine pathway.
Yuan Q; Peng J; Liu SY; Wang CJ; Xiang DX; Xiong XM; Hu CP; Li YJ
Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):630-5. PubMed ID: 20132235
[TBL] [Abstract][Full Text] [Related]
10. Effect of DL-nebivolol, its enantiomers and metabolites on the intracellular production of superoxide and nitric oxide in human endothelial cells.
Evangelista S; Garbin U; Pasini AF; Stranieri C; Boccioletti V; Cominacini L
Pharmacol Res; 2007 Apr; 55(4):303-9. PubMed ID: 17280840
[TBL] [Abstract][Full Text] [Related]
11. Accelerated onset of senescence of endothelial progenitor cells in patients with type 2 diabetes mellitus: role of dimethylarginine dimethylaminohydrolase 2 and asymmetric dimethylarginine.
Yuan Q; Hu CP; Gong ZC; Bai YP; Liu SY; Li YJ; Jiang JL
Biochem Biophys Res Commun; 2015 Mar; 458(4):869-76. PubMed ID: 25701782
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the endothelial DDAH/ADMA pathway in nitroglycerin tolerance: the role of ALDH-2.
Zhang GG; Shi RZ; Jiang DJ; Chen YR; Jia-Chen ; Tang ZY; Bai YP; Xiao HB; Li YJ
Life Sci; 2008 Mar; 82(13-14):699-707. PubMed ID: 18289604
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of Nonmuscle Myosin Light Chain Promotes Endothelial Injury in Hyperlipidemic Rats Through a Mechanism Involving Downregulation of Dimethylarginine Dimethylaminohydrolase 2.
Wu Y; Zhang JJ; Li TB; Liu WQ; Li LS; Luo XJ; Jiang JL; Ma QL; Yang ZC; Peng J
J Cardiovasc Pharmacol Ther; 2016 Nov; 21(6):536-548. PubMed ID: 26911182
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of DDAH2 and eNOS induces endothelial dysfunction in sinoaortic-denervated rats.
Feng J; Luo H; Qiu Y; Zhou W; Yu F; Wu F
Eur J Pharmacol; 2011 Jul; 661(1-3):86-91. PubMed ID: 21549701
[TBL] [Abstract][Full Text] [Related]
15. Nebivolol decreases endothelial cell stiffness via the estrogen receptor beta: a nano-imaging study.
Hillebrand U; Lang D; Telgmann RG; Hagedorn C; Reuter S; Kliche K; Stock CM; Oberleithner H; Pavenstädt H; Büssemaker E; Hausberg M
J Hypertens; 2009 Mar; 27(3):517-26. PubMed ID: 19330906
[TBL] [Abstract][Full Text] [Related]
16. Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity.
Jiang JL; Zhang XH; Li NS; Rang WQ; Feng-Ye ; Hu CP; Li YJ; Deng HW
Cardiovasc Drugs Ther; 2006 Aug; 20(4):281-94. PubMed ID: 16897158
[TBL] [Abstract][Full Text] [Related]
17. Regulation of endothelial progenitor cell differentiation and function by dimethylarginine dimethylaminohydrolase 2 in an asymmetric dimethylarginine-independent manner.
Yuan Q; Bai YP; Shi RZ; Liu SY; Chen XM; Chen L; Li YJ; Hu CP
Cell Biol Int; 2014 Sep; 38(9):1013-22. PubMed ID: 24764313
[TBL] [Abstract][Full Text] [Related]
18. Digital plethysmography and arginine metabolism in prehypertension: effect of nebivolol therapy.
Kandavar R; Fernandez C; Sander GE; Kim C; Velaga S; Sukhanov S; Delafontaine P; Egan P; Roffidal LE; Giles TD
J Clin Hypertens (Greenwich); 2015 Jan; 17(1):14-9. PubMed ID: 25495953
[TBL] [Abstract][Full Text] [Related]
19. Dimethylarginine dimethylaminohydrolase-2 overexpression improves impaired nitric oxide synthesis of endothelial cells induced by glycated protein.
Lu CW; Xiong Y; He P
Nitric Oxide; 2007 Feb; 16(1):94-103. PubMed ID: 16979918
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms underlying nebivolol-induced endothelial nitric oxide synthase activation in human umbilical vein endothelial cells.
Ladage D; Brixius K; Hoyer H; Steingen C; Wesseling A; Malan D; Bloch W; Schwinger RH
Clin Exp Pharmacol Physiol; 2006 Aug; 33(8):720-4. PubMed ID: 16895546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
